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Introduction
Nutritional status is a key factor for correct functioning of the immune system and the maintenance of health (De la Fuente & Miquel, 2009 ). States of malnutrition have been linked to higher vulnerability to infections and immune dysfunction. Malnutrition, however, is no longer restricted to nutrient deficiencies; instead, it refers broadly to inadequate nutrition and nutritional imbalance, including excessive energy intake and obesity. Indeed, obesity has been associated with impaired immune function, which is reflected in an enhanced, non-resolved inflammatory response and compromised immune surveillance (Karlsson et al. 2010; De la Fuente & De Castro, 2012; Perez de Heredia et al. 2012; Hunsche et al. 2016) . When maintained for a long time, obesity is also associated with oxidative stress, which can be mediated by either a decrease in antioxidant defences and/or increased formation of oxidants. Oxidative stress, in turn, can damage cellular structures and trigger an inflammatory response, closing a detrimental feedback loop (Perez de Heredia et al. 2012; Matsuda & Shimomura, 2013; Savini et al. 2013; Vida et al. 2014) . Research on obesity and immunity has focused mainly on circulating leucocytes, but immune organs themselves can be compromised. The largest secondary immune organ in mammals is the spleen; it hosts macrophages, dendritic cells, plasma cells and a quarter of the body's lymphocytes and is involved in several functions, such as activation of T and B cells in response to blood-borne antigens, antibody production or clearance of circulating apoptotic cells (thus contributing to peripheral immune tolerance; Cesta, 2006) . Therefore, it is important to study the impact of obesity on the spleen and on splenic leucocytes.
The last decades have witnessed a dietary transition toward a westernized dietary pattern, coincident with an increase in overweight and obesity in both developed and developing countries (Cuevas et al. 2009; Bezerra et al. 2014) . In contrast, the Mediterranean diet has been linked to lower rates of obesity (Schröder et al. 2004) , inflammation and oxidation (Savini et al. 2013) . The Mediterranean diet has been reported to modulate the immune response and to have anti-inflammatory and antioxidant properties (Minich & Bland, 2008) . This may be in great part attributable to its high content of monounsaturated (n-9; MUFAs) and polyunsaturated fatty acids (n-3; PUFAs), which have shown immunomodulatory actions (de Pablo et al. 1998; Padovese & Curi, 2009; Paschoal et al. 2013 ). The n-3 PUFAs have been more extensively studied in this respect (Calder & Grimble, 2002) , whereas less attention has been paid to the effects of MUFAs on the immune system, although they may contribute to reducing oxidative stress (Fitó et al. 2007) . Evidence regarding whether dietary MUFAs and n-3 PUFAs affect the redox state and the function of leucocytes in the spleen in obesity is, nevertheless, still scarce.
The aims of the present study were to investigate the effects of obesity on markers of oxidative stress and leucocyte functions in the spleens of mice and to evaluate the impact of subsequent supplementation with n-9 MUFA and n-3 PUFAs on these parameters.
Methods

Ethical approval
All experimental procedures were approved by the Committee for Animal Experimentation of the University Complutense of Madrid (ref. CEA-UCM 06/2012) and conducted in accordance with the guidelines and protocols of the Spanish Royal Decree 1201/2005 regarding the care and use of laboratory animals for experimental procedures. The authors acknowledge the ethical principles of Experimental Physiology and confirm that the study was conducted in compliance with the animal ethics checklist as detailed by Grundy (2015) .
Measures were taken to ensure the well-being of animals and to minimize pain and suffering to the best of our ability (see methodological description below). Organ and tissue samples were obtained post mortem. Animals were killed at the end of the study, by decapitation in the morning (08.00 h), and no anaesthetic was used to this effect to save unnecessary suffering to the animals. This procedure is in agreement with the dispositions of the European Directive 2010/63/EU. Immunosenescence in obese mice is reversed by 2-hydroxyoleic acid
Animal origin and housing conditions
Thirty-two female ICR/CD1 mice, 8 weeks of age, were purchased from Harlan Interfauna Iberica (Barcelona, Spain). The animals were housed in polyurethane cages (four animals per cage) and maintained in standard laboratory conditions (12 h-12 h reversed light-dark cycle; lights on at 20.00 h, relative humidity of 50-60%, temperature of 22 ± 2°C and adequate ventilation). During the first 5 days of acclimation to the new environment, all mice were fed a standard maintenance diet (Teklad Global 14% Protein Rodent Maintenance Diet, reference 2014; Harlan Interfauna Iberica).
Experimental groups and diets
Animals were split into the following two groups: eight mice kept receiving the maintenance diet for the entire duration of the study (18 weeks), constituting the control group, whereas the rest received a moderately fat-rich diet for 4 weeks (3.3 kcal g (Fig. 1) .
At this point, the high-fat diet-fed mice were split into the following three groups: eight mice kept receiving the obesogenic diet for the rest of the experiment (OD group); eight mice were given the diet supplemented with 2-OHOA (1500 mg kg −1 of diet; OD-HO group); and eight mice were given the diet supplemented with a combination of eicosapentaenoic acid (EPA, 20:5n-3, 1500 mg kg −1 of diet) and docosahexaenoic acid (DHA, 22:6n-3, 1500 mg kg −1 of diet; OD-N3 group), for an additional 6 weeks. The 2-OHOA is a synthetic derivative of oleic acid with a hydroxyl group in the α-position, and it is also known as 2-hydroxy-D9-cis-octadecenoic acid. The n-3 PUFAs were extracted from fish (anchovy). All fatty acid supplements were provided by BTSA-Biotecnologías Aplicadas, SL. Upon reception of the supplements (2-OHOA in powdered form and n-3 PUFAs in oil form), these were mixed at our facilities with the diet, which was of a malleable consistency, and then pelleted before being presented to the mice. Animals had free access to water and food during the entire study, and food intake was monitored on a weekly basis.
Collection of spleen and leucocyte suspensions
After the animals had been killed, their spleens were harvested aseptically and freed from fat. One fragment of each spleen was stored at −80°C for the study of oxidative stress parameters. Another fragment of spleen was minced with scissors and gently pressed through a mesh screen (Sigma, St Louis, MO, USA) to obtain cell suspensions. The cell suspensions were centrifuged in a gradient of Ficoll-Hypaque (Sigma) with a density of 1.070 g ml −1 ; cells from the interface were collected and suspended in Roswell Park Memorial Institute (RPMI) 1640 medium enriched with L-glutamine (PAA, Pasching, Austria) and supplemented with 10% heat-inactivated fetal calf serum (Gibco, Canada) and 1% gentamicin (100 μg ml −1 ; Gibco). After a wash step, leucocytes were counted in a Neubauer chamber and their number adjusted to 10 6 cells ml −1 . Cell viability was routinely measured before each experiment by the Trypan Blue exclusion test, and was >95% in all experiments. All incubations were performed at 37°C in a humidified atmosphere of air enriched with 5% CO 2 . 
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Analysis of oxidative stress
Levels of reduced glutathione and oxidized glutathione.
Reduced glutathione (GSH) is one of the most important antioxidant defence mechanisms in the organism and, as such, a relevant marker of its antioxidant capacity. Both GSH and oxidized glutathione (GSSG) were determined in spleen using a fluorimetric method (Hissin & Hilf, 1976) . This is based on the reaction of a fluorescence probe, o-phthaldialdehyde (OPT), with GSH at pH 8 and with GSSG at pH 12, which generates a fluorescence derivative. The spleen samples were homogenized (50 mg ml −1 ) in sodium phosphate-EDTA buffer (0.1 M, pH 8), and proteins were precipitated by adding 5 μl of 60% perchloric acid. Homogenized spleen samples were centrifuged (9500g for 10 min at 4°C), and supernatants were maintained in ice for measurement of GSH and GSSG levels. For the determination of GSH levels, 10 μl of the supernatant, 190 μl of sodium phosphate-EDTA buffer and 20 μl of OPT solution (1 mg ml −1 in methanol) were added to a 96-well black microplate and incubated at room temperature for 15 min. Fluorescence was determined in a microplate reader using excitation at 350 nm and emission detection at 420 nm. For the determination of GSSG levels, 10 μl of the supernatant and 4 μl of N-ethylmaleimide (NEM, 0.04 M) were added to a 96-well black microplate and incubated at room temperature for 30 min. Then, 186 μl of sodium hydroxide (0.1 N) with 20 μl of OPT solution were added to each well. After incubation (room temperature, 15 min), fluorescence was measured as previously described for GSH determination. The results were analysed with GSH and GSSG standard curves at different concentrations and expressed as nmoles per milligram of protein. The protein concentration of the samples was measured following the bicinchoninic acid protein assay kit protocol (Sigma-Aldrich, Madrid, Spain). The GSSG/GSH ratio was then calculated for each sample. All assays were performed in duplicate.
Activity of xanthine oxidase. Xanthine oxidase (XO) activity was assayed by fluorescence in homogenates of spleen, using a commercial kit (Amplex Red Xanthine/Xanthine Oxidase Assay Kit; Molecular Probes, Paisley, UK). In the assay, XO catalyses the oxidation of purine bases (xanthine) to uric acid and superoxide anions. The superoxide anion spontaneously degrades in the reaction mixture to H 2 O 2 , which in the presence of horseradish peroxidase reacts with Amplex Red reagent to generate the red-fluorescent oxidation product, resorufin. Tissue samples were homogenized in phosphate buffer (50 mM, pH 7.4) containing 1 mM EDTA and normalized to total protein. The homogenate was centrifuged (5000g) and the supernatant (50 μl) collected and incubated with 50 μl working solution of Amplex Red reagent (100 μM) containing horseradish peroxidase (0.4 U ml −1 ) and xanthine (200 μM). After 30 min of incubation at 37°C, measurement of fluorescence was performed in a microplate reader (Fluostar Optima, BMG Labtech, Biomedal, Spain), using excitation at 530 nm and emission detection at 595 nm. Xanthine oxidase supplied in the kit was used as the standard. The results were expressed as international milliunits of enzymatic activity per milligram of protein (milliunits of XO per milligram of protein). The protein content of the samples had been assessed previously by the bicinchoninic acid protein assay kit protocol (Sigma-Aldrich, Madrid, Spain). All assays were performed in duplicate.
Lipid peroxidation. Lipid peroxidation levels were determined by measuring the formation of malondialdehyde (MDA) using a colorimetric assay kit (BioVision, Inc., Mountain View, CA, USA). The spleen samples were homogenized (10 mg) in 300 μl of MDA lysis buffer with 3 μl butylhydroxytoluene (BHT; ×100 concentration) and centrifuged (13,000g for 10 min) to remove insoluble material. An aliquot (200 μl) of each supernatant was added to 600 μl of thiobarbituric acid and incubated at 95°C for 60 min. The samples were then maintained in an ice bath for 10 min, and 200 μl from each 800 μl reaction mixture was placed into a 96-well microplate for spectrophotometric measurement at 532 nm. The results were analysed with an MDA standard curve at different concentrations and expressed as nmoles per milligram of protein. The protein concentration of the samples was measured following the bicinchoninic acid protein assay kit protocol (Sigma-Aldrich, Madrid, Spain). All assays were performed in duplicate.
Leucocyte functions
Chemotaxis assay. The assay was carried out following the method previously described by De la Fuente et al. (2004) . Chambers with two compartments separated by a filter of 3 μm pore diameter (Millipore, Cork, Ireland) were used. Aliquots of 300 μl of leucocyte suspensions were placed in the upper compartment, and 400 μl of the chemoattractant fMet-Leu-Phe (fMLF; Sigma), at a concentration of 10 −8 M, were placed in the lower compartment. After 3 h incubation, the filters were fixed and stained, and the number of lymphocytes on the lower face of the filters was counted in one-third of them, with an optical microscope, and recorded as the chemotaxis index (CI). All the samples were assayed in duplicate.
Natural killer (NK) activity assay. An enzymatic colorimetric assay was used for measurements of cytolysis of target cells (Cytotox 96 TM Promega; Boeringer Ingelheim, Germany), based on the determination of the activity of the enzyme lactate dehydrogenase and using tetrazolium salts, as previously published (De la Fuente et al. 2004) . Briefly, target cells (YAC-1 cells from a murine lymphoma) were seeded in 96-well U-bottomed culture plates (Nunclon, Roskilde, Denmark) in RPMI 1640 medium without Phenol Red, at a concentration of 10 4 cells per well. Effector cells (leucocytes from spleen) were added at a concentration of 10 5 cells per well, thus obtaining an effector/target rate of 10/1. The plates were centrifuged at 250g for 4 min to facilitate cell-to-cell contact and then incubated for 4 h. After incubation, plates were centrifuged again at 250g for 4 min, and lactate dehydrogenase activity was measured in the supernatants (50 μl per well) by addition of the enzyme substrate with absorbance recording at 490 nm. The results were expressed as the percentage of lysis. Each sample was assayed in triplicate. Three kinds of control measurements were performed, namely a target spontaneous release, a target maximal release and an effector spontaneous release. To determine the percentage of lysis of target cells, the following equation was used:
where E is the mean absorbance in the presence of effector cells, ES is the mean absorbance of effector cells incubated alone (effector spontaneous release), TS is the mean absorbance in target cells incubated with medium alone (target spontaneous release), and M is the mean of maximal absorbance after incubating target cells with lysis solution (target maximal release).
Lymphoproliferation assay. Following the method previously described (De la Fuente et al. 2004) , aliquots (200 μl) of leucocytes (10 6 cells ml −1 of complete medium) were seeded in 96-well flat-bottomed microtitre plates (Nunc, Roskilde, Denmark). Twenty microlitres of concanavalin A (ConA, 1 μg ml −1 ; Sigma, St Louis, MO, USA) or 20 μl of lipopolysaccharide (LPS; Escherichia coli 055:B5, 1 μg ml −1 ; Sigma) was added per well. In order to assess spontaneous proliferation, 20 μl of complete medium was added to some wells instead of the mitogens. After 48 h of incubation at 37°C in an atmosphere of air enriched with 5% CO 2 , 0.5 μCi 3 H-thymidine (Du Pont, Boston, MA, USA) was added to each well. The cells were harvested in a semiautomatic microharvester 24 h later. Thymidine uptake was measured using a β-counter (LKB, Uppsala, Sweden). The results were expressed as 3 H-thymidine uptake (in counts per minute; cpm). All assays were performed in triplicate.
Statistical analysis
We tested the following hypotheses: (i) spleens from obese animals would be subjected to higher oxidative stress than those from control animals; (ii) leucocytes from spleens of obese animals would present altered chemotaxis, NK activity and proliferation in response to mitogens in relation to control animals; and (iii) supplementation with 2-OHOA or n-3 PUFAs would reverse the observed changes.
The sample size was eight per experimental group (unless otherwise specified), with assays being conducted in triplicate (NK activity and lymphoproliferation) or duplicate (the rest of the assays). In those cases, the average value of the replicas was used. The results are expressed as means ± SD, or medians and interquartile range (IQR), depending upon normality of the data, which was checked by the Shapiro-Wilk test. For normally distributed variables (XO activity, MDA levels, CI, NK activity and proliferation), one-way ANOVA with Bonferroni post hoc test were conducted to compare the four experimental groups. For non-normally distributed variables (body weight, GSH and GSSG levels and GSSG/GSH), the Kruskal-Wallis test was used to compare the four experimental groups and the Mann-Whitney U test was used to run pairwise comparisons when the Kruskal-Wallis test was significant. The significance level was always set at P < 0.05. All statistical tests were performed using IBM SPSS v23, Armonk, NY, USA.
Results
Effect of the treatments on body weight gain
The animals fed the obesogenic diet started gaining significantly more weight than the controls after 5 weeks of high-fat feeding (P = 0.036). Supplementation with 2-OHOA resulted in progressive reduction of body weight, and at the end of the experiment the average weight of the OD-HO group was significantly lower than that of control animals (P = 0.009). The supplementation with n-3 PUFAs did not have a significant effect on body weight when compared with the OD group (Fig. 2, Table S1 ).
Effect of the treatments on the oxidative stress parameters in spleen
The levels of GSH were similar among experimental groups (P = 0.518; Fig. 3A) . On the contrary, the levels of GSSG and the GSSG/GSH ratios were significantly different between groups (P = 0.003 and P = 0.013, respectively). The OD group presented the highest values; treatment with 2-OHOA seemed to prevent or reverse the increase in both GSSG levels and GSSG/GSH, whereas n-3 PUFAs seemed to ameliorate only the increase in GSSG/GSH (Fig. 3B and C, Table S2 ). Likewise, xanthine oxidase activity (Fig. 4) was different among experimental groups (P = 0.015). The highest value corresponded to the OD group (P = 0.032 versus control), and the increase A. Gheorghe and others was abolished by supplementation with n-3 PUFAs (P = 1.000 and P = 0.032 versus control and OD groups, respectively), and partly by 2-OHOA (P = 1.000 and P = 0.114 versus control and OD groups, respectively) (Table S3) . Lipid peroxidation (measured as MDA levels) was also different among treatments (P = 0.004), with differences being found between the OD and OD-HO groups (P = 0.012) and between the OD-HO and OD-N3 groups (P = 0.017; Fig. 5 , Table S4 ).
Effect of treatments on splenic leucocyte functions
Significant differences were found among the experimental groups for the CI of spleen lymphocytes (P < 0.001), which was lowest in the control group and highest in the OD group. Supplementation with 2-OHOA partly prevented or reversed the increase in the CI (P = 0.002 versus the OD group), but no significant effect could be attributed to n-3 PUFA supplementation (P = 0.863 versus the OD group; Fig. 6 , Table S5 ). In contrast, the NK activity of splenic leucocytes was higher in the control group than in all groups fed the obesogenic diet (P = 0.003), with no statistical differences observed between the OD group and the groups that received the fatty acid supplements (P = 1.000 for both post hoc contrasts; Fig. 7 , Table S6 ). Arrows indicate the weeks when the average body weights started to differ significantly between control animals and obesogenic diet-fed animals (P = 0.036), and between the OD-HO group and the other two obesogenic diet-fed groups (P = 0.011), as analysed by the Kruskal-Wallis test. .00 Figure 3 . Levels of reduced glutathione (GSH; A), oxidized glutathione (GSSG; B) and the GSSG/GSH ratio (C) in the spleen homogenates of mice from the four experimental groups n = 6 animals per group. All assays were performed in duplicate. Differences between treatments were analysed with the Mann-Whitney U test: * P < 0.05 and * * P < 0.01.
With regard to the proliferative capacity of lymphocytes, no significant differences were observed between groups in basal conditions (control group, 1395 ± 550 cpm; OD group, 1283 ± 463 cpm; OD-HO group, 1363 ± 346 cpm; and OD-N3 group, 1193 ± 361 cpm). In response to stimulation by ConA, the OD group showed the lowest values of proliferation (P < 0.001), a decrease that was totally reversed by supplementation with 2-OHOA and partly reversed by supplementation with n-3 PUFAs (Fig. 8A) . In response to LPS stimulation, the obesogenic diet per se did not result in a significant alteration of the lymphoproliferative response, but the supplementation with 2-OHOA was accompanied by higher levels of proliferation, in comparison with both the control group (P < 0.001) and the OD group (P = 0.002; Fig. 8B , Table S7 ).
Discussion
The results of the present study support the suggestion that the induction of dietary obesity during the juvenile period leads to the development of obesity, oxidative stress and impaired leucocyte function in the spleen in adulthood. The supplementation with 2-OHOA, and to a lesser extent with n-3 PUFAs (EPA + DHA), was able to ameliorate the alteration of most leucocyte functions partly or completely and to improve the oxidative stress status in the obese mice.
We found that 2-OHOA but not n-3 PUFA supplementation led to a progressive decrease in body weight. This was not accompanied by a decrease in food intake (data not shown). Our results are in agreement with Vögler and colleagues (2008) , who previously reported that 2-OHOA-treated mice experienced a decrease in body weight through reduction of adipose fat mass. With regard to n-3 PUFAs, despite a considerable body of evidence (Thorsdottir et al. 2007; Buckley & Howe, 2010) , a recent meta-analysis indicated that PUFA supplementation does not promote anti-obesity effects in overweight/obese individuals, in agreement with our results (Du et al. 2015) . The obese animals in our study presented increased oxidative stress and altered function of leucocytes in the spleen. Obesity is a risk factor for the progressive deterioration of cellular immune functions (Tarantino et al. 2013) and has been associated with premature immunosenescence, a situation of both oxidative and inflammatory stress (De la Fuente & De Castro, 2012; De la Fuente, 2014 ). The pathophysiological mechanisms by which cellular immune functions are affected by obesity are still under investigation, but the spleen may play an important role (Tarantino et al. 2013) . The increased oxidative stress in our mice was manifested by higher GSSG, GSSG/GSH ratio, lipid peroxidation and xanthine oxidase activity levels. This suggests that obesity was accompanied by elevated formation of oxidants rather than a decrease in the levels of antioxidants, at least in the spleen. This is the first time, to our knowledge, .00 C OD OD-HO OD-N3 GROUP Lipid peroxidation (nmol MDA/mg prot) Figure 5 . Lipid peroxidation, measured as levels of malondialdehyde (MDA), in the spleen homogenates of mice from the four experimental groups Number of animals was as follows: C group, n = 6; OD group, n = 6; OD-HO group, n = 4; and OD-N3 group, n = 5. All assays were performed in duplicate. Boxplots represent means, 95% confidence intervals, minimal and maximal values. Different superscript letters indicate significant differences as analysed by one-way ANOVA with post hoc correction by Bonferroni test, P < 0.05.
A. Gheorghe and others that GSH, GSSG and the GSSG/GSH ratio have been investigated in the spleen of diet-induced obese mice, but our results are in agreement with previous studies that looked at other organs and/or species (Capel & Dorrell, 1984; Kolesnikova et al. 2013; Hunsche et al. 2016 ). An increased GSSG/GSH ratio has been associated with a number of diseases, including type 2 diabetes (Lee et al. 2008) , and it can therefore be a useful health marker in the assessment of obesity-related co-morbidities. In a similar manner, the activity of XO in the thymus has been reported to be higher in obese rats than in normal-weight control animals (De la Fuente & De Castro, 2012) and to be elevated in obese children when compared with non-obese children (Chiney et al. 2011) . In our study, the supplementation with unsaturated fatty acids proved to be effective at improving the oxidative state of obese mice; 2-OHOA supplementation reduced both GSSG levels and the GSSG/GSH ratio, as well as MDA levels (the marker of lipid peroxidation), when compared with the OD group, while XO activity was decreased by n-3 PUFA supplementation (in relation to the OD group). Our results are in agreement with previous evidence showing that olive oil consumption can favour tissue antioxidant defence mediated by the glutathione system (De La Cruz et al. 2000) , reduce lipid peroxidation levels (El-Kholy et al. 2014) and improve plasma antioxidant capacity (Pitsavos et al. 2005) . In our study, obese animals also presented higher chemotaxis, lower cytotoxic activity and lower mitogeninduced proliferation in splenic leucocytes. The capacity for chemotaxis enables the migration of circulating immune cells into tissues and their accumulation in sites of infection or injury, in order to produce an adequate inflammatory and defensive response (Doherty et al. 1987) . Understanding the significance of increased chemotaxis in our obese mice would require further research, as evidence available is not unanimous in this respect. On the one hand, decreased chemotaxis has been reported in neutrophils from genetically obese mice (Kordonowy et al. 2012) and in peritoneal immune cells from aged mice, which are in a state of oxidative stress (De la Fuente & Miquel, 2009 ). On the other hand, an increase in the chemotactic indices of splenic lymphocytes was observed in a mouse model of Alzheimer's disease, another condition with a high oxidative situation (Giménez-Llort et al. 2008) , whereas another study showed enhanced immune cell chemotaxis in mice fed a high-fat diet (Qiao et al. 2009 ). High fat consumption has been reported to induce activation of cellular adherence (Esser et al. 2013 ), which in turn is linked to oxidative stress (De la Fuente & Miquel, 2009 ). The increased chemotaxis observed in our study, therefore, is likely to be related to the oxidative stress state of the obese mice. It is important, however, to highlight that changes in chemotactic function can be dependent on the types of immune cells and organs analysed. Supplementation with 2-OHOA, but not with n-3 PUFA, was able to partly prevent or reverse the rise in the CI associated with obesity in our mice. In agreement with our findings, previous studies have reported no effect of n-3 PUFAs on neutrophil chemotaxis (Schmidt et al. 1996; Healy et al. 2000; Hill et al. 2007) , although other authors did observe diminished neutrophil chemotaxis in response to these fatty acids (Lee et al. 1985; Luostarinen et al. 1992; Schmidt et al. 1992; Sperling et al. 1993) . In relation to 2-OHOA, our study is, to our knowledge, the first to report a significant amelioration of obesity-related changes in splenic leucocyte chemotaxis.
Natural killer cytotoxic activity was lower in all the groups fed the obesogenic diet. These results are consistent with previous studies indicating that high-fat-fed mice, obese rats and obese humans suffer from diminished NK cell cytotoxicity (Morrow et al. 1985; Moriguchi et al. 1998; Lamas et al. 2004; O'Shea et al. 2010; De la Fuente & De Castro, 2012) . Natural killer cells constitute the most important defensive line against malignant and virus-infected cells. Thus, a decrease in their activity renders the animals more susceptible to infections and tumours. Interestingly, similar changes in NK activity have been observed in old and prematurely ageing animals (De la Fuente et al. 2004; De la Fuente & Miquel, 2009 ). In our study, neither 2-OHOA nor n-3 PUFA supplementation resulted in any improvement of NK activity, in agreement with previous work (Berger et al. 1993; Yaqoob et al. 2000) . Therefore, we can speculate that changes in NK activity in our study were not directly linked to the oxidative stress status of the animals, but to other alterations associated with obesity and/or high fat intake.
Finally, obesity in our study was accompanied by a decreased lymphoproliferative response after stimulation with the mitogen ConA, but not with LPS or in basal conditions. Concanavalin A is a T-cell mitogen, whereas LPS acts as a B-cell mitogen. These different mitogen actions could explain why the experimental treatments did not affect proliferation in all conditions, and suggest instead that obesity impacts specifically on certain types of immune cells (Pérez-de-Heredia et al. 2015) . In addition, we did not observe statistically significant differences in the percentages of CD3 + cells (T lymphocytes) and CD19 + cells (B lymphocytes) among the experimental groups (data not shown), which would be in agreement with the lack of proliferative response to LPS and with the similar levels of lymphoproliferation in the basal state. We can only speculate at this point, but our results could suggest that obesity and/or the high-fat diet did not affect the basal proliferation capacity of lymphocytes per se, but could impair the ability of the spleen to respond to an offense by increasing the population of T lymphocytes specifically. More research is needed to understand the pathways and mechanisms by which obesity can impact lymphocyte maturation in the spleen. Supplementation with 2-OHOA led to restored lymphoproliferation levels in response to ConA and resulted in a higher proliferative response to LPS stimulation in our study, whereas n-3 PUFA supplementation did not significantly affect either ConA-or LPS-stimulated proliferation. Other authors, on the contrary, have reported lower olive oil-induced lymphoproliferative response to both ConA and LPS, when compare with other types of fat (de Pablo et al. 1998) and that n-3 PUFAs could reduce in vitro lymphocyte proliferation (Peterson et al. 1998) . Further research is also required in order to confirm the effects of both 2-OHOA and n-3 PUFAs in modulating the proliferation of splenic leucocytes.
Our study has certain limitations that should be addressed. Additional measures of antioxidant markers, such as the total antioxidant capacity of the spleen, A. Gheorghe and others could contribute to confirm our hypothesis that oxidative stress in obesity is attributable to increased generation of oxidants rather than decreased antioxidant defence mechanisms. The analysis of the activity of the enzymes glutathione peroxidase and glutathione reductase could contribute to explain the results obtained in relation to levels of GSH and GSSG. Likewise, analysis of the activity of superoxide dismutase could shed light on the results obtained in relation to xanthine oxidase. Unfortunately, the amount of tissue available limited the number of analyses that could be conducted on the spleens. In this line, it would also have been interesting to analyse antioxidant markers in plasma, in order to confirm the oxidative stress state associated with obesity, but again the amount of blood available from each mouse was limited, and it was necessary to conduct a set of humoral and metabolic determinations.
In conclusion, early induction of dietary obesity led to oxidative stress and impaired leucocyte function in mice, suggesting premature immunosenescence. Supplementation with 2-OHOA or, to a lesser extent, with n-3 PUFAs was able to reduce body weight and to ameliorate the oxidative stress and alteration of several leucocyte functions in the spleens of obese mice.
